semaglutide alcohol craving Many patients taking GLP-1 medications like Ozempic and Wegovy say they notice something unexpected: less interest in alcohol. Now, new research suggests there may be a reason why. A recent study found People with obesity and alcohol

As part of comprehensive care

Resistance Training: Weight loss from GLP-1s can include muscle loss if you arent careful

Safety and adverse events No serious adverse events were reported in the study of Takahashi et al (19)

Medicare: Part D plans cover Ozempic for diabetes, certain cardiac, or kidney conditions, but not for weight loss

CrossRef Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data Ha Young Jang, In-Wha Kim, Jung Mi Oh Frontiers in Pharmacology.2022;[Epub] CrossRef Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin Ai-Yu Yang, Hung-Chun Chen International Journal of Clinical Pharmacy.2021